Timeline tool
Research Protocol Simulator
Generate a 4, 8 or 12-week research-stage protocol with induction, titration, maintenance and taper phases. Suggested blood-marker checkpoints are layered onto each phase.
Simulate a protocol
Lower starts produce gentler titration ramps.
Reference research range: 250 – 2400 mcg per administration.
Phase timeline
- 1Induction· 3 weeks1200 mcg per dose
Familiarisation with delivery and tolerability checkpoints.
- 2Titration· 3 weeks1800 mcg per dose
Step-wise dose increase; record blood-marker baselines.
- 3Maintenance· 5 weeks2400 mcg per dose
Held at typical research dose; mid-protocol blood panel.
- 4Taper· 1 week1800 mcg per dose
Gradual reduction to baseline; final marker check.
Why phased protocols?
Every well-designed research protocol begins with a brief induction phase (familiarisation with the delivery route and a tolerability check at a sub-therapeutic dose), followed by a titration phase that steps the dose upward, a maintenance phase at the research-target dose, and a short taper phase that reduces dose-discontinuation rebound effects.
Blood-marker checkpoints
A baseline panel is recommended before the induction phase; a mid-protocol panel at the start of maintenance; and a final panel two weeks after the taper completes. Specific markers depend on the peptide class — IGF-1 for GH-class peptides, HbA1c and fasting glucose for incretins, lipid panel and inflammation markers for healing-class peptides.